TY - JOUR
T1 - HPLC assay for basic amine drug in plasma using a silica gel column and an aqueous mobile phase-application in a pilot bioavailability study of chlorpheniramine controlled-release dosage form
AU - Pao, Li Heng
AU - Hu, Oliver Yoa Pu
PY - 1994/1/1
Y1 - 1994/1/1
N2 - A high performance liquid chromatographic (HPLC) method that involves the use of a silica gel column and an aqueous mobile phase for simultaneous separation of chlorpheniramine, pseudoephedrine and terfenadine in plasma is presented. Alkalized samples are cleaned by extraction with n-hexane, and the extraction is followed by evaporating the solvent and reconstituting the residue in a small amount of mobile phase. An aliquot of this solution is analyzed by a HPLC system with a silica gel column, an aqueous mobile phase containing 55% CH3CN and 45% (NH4)H2PO4(pH 4.0), and UV detection at 210 nm. The low detection limits of the method in plasma are 1 ng, 4 ng and 0.5 ng for chlorpheniramine, pseudoephedrine and terfenadine, respectively. In this study, terfenadine acts as an internal standard. The coefficient of variance on the results of intraday and interday precision and the accuracy on control samples of chlorpheniramine and pseudoephedrine were all within 10% We have used this method successfully in a pilot bioavailability study of a newly developed controlled-release formulation.
AB - A high performance liquid chromatographic (HPLC) method that involves the use of a silica gel column and an aqueous mobile phase for simultaneous separation of chlorpheniramine, pseudoephedrine and terfenadine in plasma is presented. Alkalized samples are cleaned by extraction with n-hexane, and the extraction is followed by evaporating the solvent and reconstituting the residue in a small amount of mobile phase. An aliquot of this solution is analyzed by a HPLC system with a silica gel column, an aqueous mobile phase containing 55% CH3CN and 45% (NH4)H2PO4(pH 4.0), and UV detection at 210 nm. The low detection limits of the method in plasma are 1 ng, 4 ng and 0.5 ng for chlorpheniramine, pseudoephedrine and terfenadine, respectively. In this study, terfenadine acts as an internal standard. The coefficient of variance on the results of intraday and interday precision and the accuracy on control samples of chlorpheniramine and pseudoephedrine were all within 10% We have used this method successfully in a pilot bioavailability study of a newly developed controlled-release formulation.
UR - http://www.scopus.com/inward/record.url?scp=0027994552&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027994552&partnerID=8YFLogxK
U2 - 10.3109/03639049409042672
DO - 10.3109/03639049409042672
M3 - Article
AN - SCOPUS:0027994552
SN - 0363-9045
VL - 20
SP - 2695
EP - 2706
JO - Drug Development and Industrial Pharmacy
JF - Drug Development and Industrial Pharmacy
IS - 17
ER -